Suppr超能文献

COVID-19 人体挑战研究的伦理审查:HRA/WHO 联合研讨会。

Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop.

机构信息

Department of Microbiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia.

Specialist Ad-Hoc Research Ethics Committee for COVID-19 Human Challenge Studies, Health Research Authority, London, UK.

出版信息

Vaccine. 2022 Jun 9;40(26):3484-3489. doi: 10.1016/j.vaccine.2022.02.004. Epub 2022 Feb 14.

Abstract

This report of a joint World Health Organization (WHO) and United Kingdom (UK) Health Research Authority (HRA) workshop discusses the ethics review of the first COVID-19 human challenge studies, undertaken in the midst of the pandemic. It reviews the early efforts of international and national institutions to define the ethical standards required for COVID-19 human challenge studies and create the frameworks to ensure rigorous and timely review of these studies. This report evaluates the utility of the WHO's international guidance document Key criteria for the ethical acceptability of COVID-19 human challenge studies (WHO Key Criteria) as a practical resource for the ethics review of COVID-19 human challenge studies. It also assesses the UK HRA's approach to these complex ethics reviews, including the formation of a Specialist Ad-Hoc Research Ethics Committee (REC) for COVID-19 Human Challenge Studies to review all current and future COVID-19 human challenge studies. In addition, the report outlines the reflections of REC members and researchers regarding the ethics review process of the first COVID-19 human challenge studies. Finally, it considers the potential ongoing scientific justification for COVID-19 human challenge studies, particularly in relation to next-generation vaccines and optimisation of vaccination schedules. Overall, there was broad agreement that the WHO Key Criteria represented an international consensus document that played a powerful role in setting norms and delineating the necessary conditions for the ethical acceptability of COVID-19 human challenge studies. Workshop members suggested that the WHO Key Criteria could be practically implemented to support researchers and ethics reviewers, including in the training of ethics committee members. In future, a wider audience may be engaged by the original document and potential additional materials, informed by the experiences of those involved in the first COVID-19 human challenge studies outlined in this document.

摘要

本报告是世界卫生组织(世卫组织)和联合王国(英国)卫生研究管理局(HRA)联合举办的一次研讨会的报告,讨论了在大流行期间首次进行的 COVID-19 人体挑战研究的伦理审查问题。它审查了国际和国家机构为 COVID-19 人体挑战研究确定所需伦理标准并创建框架以确保对这些研究进行严格和及时审查的早期努力。本报告评估了世卫组织关于 COVID-19 人体挑战研究的伦理可接受性的国际指导文件《COVID-19 人体挑战研究的关键标准》(世卫组织关键标准)作为 COVID-19 人体挑战研究伦理审查实用资源的效用。它还评估了英国 HRA 对这些复杂伦理审查的方法,包括成立一个专门的临时研究伦理委员会(REC)来审查所有当前和未来的 COVID-19 人体挑战研究。此外,该报告概述了 REC 成员和研究人员对首次 COVID-19 人体挑战研究的伦理审查过程的反思。最后,它考虑了 COVID-19 人体挑战研究在未来可能存在的科学依据,特别是在新一代疫苗和优化疫苗接种时间表方面。总体而言,与会者广泛认为,世卫组织关键标准是一份国际共识文件,在为 COVID-19 人体挑战研究的伦理可接受性设定规范和划定必要条件方面发挥了强大作用。研讨会成员建议,可以实际实施世卫组织关键标准来支持研究人员和伦理审查人员,包括对伦理委员会成员进行培训。在未来,可能会有更广泛的受众参与到原始文件和潜在的补充材料中来,这些材料是根据本文件中概述的首次 COVID-19 人体挑战研究参与者的经验提供的。

相似文献

1
Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop.
Vaccine. 2022 Jun 9;40(26):3484-3489. doi: 10.1016/j.vaccine.2022.02.004. Epub 2022 Feb 14.
2
Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group.
Vaccine. 2021 Jan 22;39(4):633-640. doi: 10.1016/j.vaccine.2020.10.075. Epub 2020 Oct 28.
3
Surveying the Indian research ethics committee response to the COVID-19 pandemic.
Dev World Bioeth. 2024 Sep;24(3):243-253. doi: 10.1111/dewb.12417. Epub 2023 Aug 4.
5
Evidence from UK Research Ethics Committee members on what makes a good research ethics review, and what can be improved.
PLoS One. 2023 Jul 3;18(7):e0288083. doi: 10.1371/journal.pone.0288083. eCollection 2023.
7
The readiness of the Asian research ethics committees in responding to the COVID-19 pandemic: A multi-country survey.
F1000Res. 2024 Jan 8;13:19. doi: 10.12688/f1000research.143138.1. eCollection 2024.
9
UK Research Ethics Committee's review of the global first SARS-CoV-2 human infection challenge studies.
J Med Ethics. 2023 May;49(5):322-324. doi: 10.1136/medethics-2021-107709. Epub 2021 Oct 5.

引用本文的文献

2
Response to comment about article 'changes in memory and cognition during the SARS-CoV-2 human challenge study'.
EClinicalMedicine. 2025 Mar 1;81:103143. doi: 10.1016/j.eclinm.2025.103143. eCollection 2025 Mar.
4
Ethical approval for controlled human infectious model clinical trial protocols - A workshop report.
Biologicals. 2024 Feb;85:101748. doi: 10.1016/j.biologicals.2024.101748. Epub 2024 Feb 12.
5
Regulatory workshop on challenge strain development and GMP manufacture - A stakeholder meeting report.
Biologicals. 2024 Feb;85:101746. doi: 10.1016/j.biologicals.2024.101746. Epub 2024 Feb 3.
6
Safety risks and ethical governance of biomedical applications of synthetic biology.
Front Bioeng Biotechnol. 2023 Oct 24;11:1292029. doi: 10.3389/fbioe.2023.1292029. eCollection 2023.

本文引用的文献

3
Vaccines for COVID-19: Where do we stand in 2021?
Paediatr Respir Rev. 2021 Sep;39:22-31. doi: 10.1016/j.prrv.2021.07.001. Epub 2021 Jul 12.
4
The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic.
Curr Biol. 2021 Jul 26;31(14):R918-R929. doi: 10.1016/j.cub.2021.06.049. Epub 2021 Jun 23.
5
SARS-CoV-2 Human Challenge Studies - Establishing the Model during an Evolving Pandemic.
N Engl J Med. 2021 Sep 9;385(11):961-964. doi: 10.1056/NEJMp2106970. Epub 2021 Jul 21.
8
Confronting Our Next National Health Disaster - Long-Haul Covid.
N Engl J Med. 2021 Aug 12;385(7):577-579. doi: 10.1056/NEJMp2109285. Epub 2021 Jun 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验